Med J Aust. 1992 Sep 7;157(5):340-3.
To establish consensus statements for the use of human albumin solutions in clinical situations identified as responsible for the major use of human albumin products.
Working parties comprised of specialists in intensive care, renal medicine, cardiothoracic anaesthesia, gastroenterology, haematology and transfusion medicine, were convened to develop consensus statements for the use of human albumin solutions.
Specific statements have been formulated to guide the clinician in the use of human albumin solutions for hypovolaemia or hypoalbuminaemia (particularly in intensive care units), cardiothoracic surgery, therapeutic plasma exchange and patients with ascites or protein-losing states in gastroenterology.
These statements, with wide dissemination, will promote consistency in the use of human albumin products in clinical practice and become a reference for future audits on the use of these products.
针对被认定为人类白蛋白产品主要使用场景的临床情况，制定关于使用人白蛋白溶液的共识声明。
召集了由重症监护、肾脏医学、心胸麻醉、胃肠病学、血液学和输血医学领域的专家组成的工作小组，以制定关于使用人白蛋白溶液的共识声明。
已制定具体声明，以指导临床医生在治疗低血容量或低白蛋白血症（尤其是在重症监护病房）、心胸外科手术、治疗性血浆置换以及胃肠病学中腹水或蛋白丢失状态患者时使用人白蛋白溶液。
这些声明若能广泛传播，将促进临床实践中使用人白蛋白产品的一致性，并成为未来对这些产品使用情况进行审核的参考依据。
